AI drug discovery company

Excelsior

Data as of Oct 17, 2026.

Company facts

Founded

2024

ReportedSource for founded (opens in new tab)
Headquarters

United States (New York, NY)

ReportedSource for headquarters (opens in new tab)

Latest funding round

Round: Series A
Date: Dec 2025
Amount: $70M
Lead investor: Deerfield Management, Khosla Ventures and Sofinnova Partners (co-leads)

ReportedSource for the latest round (opens in new tab)

Recent news

Jun 2026

SCI profile on its machine-readable "smart bloccs" chemistry

ReportedSource (opens in new tab)
Dec 3, 2025

Excelsior Sciences raises $95M for small molecule discovery and manufacturing chemistry that machines can run

ConfirmedSource (opens in new tab)

Confirmed means the company, a partner or a filing said it. Reported means a third party said it. This section sits outside the Pharma AI Tracker.

Spot an error? Tell me and I'll fix it.